Posted by Michael Wonder on 15 Jan 2019
House Democrats launch drug pricing probe into a dozen major health care companies
14 January 2019 - Chairman Elijah Cummings sent letters to AbbVie, Amgen, AstraZeneca, Celgene, Eli Lilly, Johnson & Johnson, Mallinckrodt, Novartis, Novo Nordisk, Pfizer, Sanofi and Teva Pharmaceuticals.
The House Oversight Committee is investigating the actions of a dozen pharmaceutical companies in raising prescription drug prices in the U.S., the panel announced Monday.
AbbVie and Sanofi received information requests regarding three of their drugs, the panel said. Amgen, Pfizer and Novo Nordisk received requests about two drugs. AstraZeneca, Celgene, Eli Lilly, Johnson & Johnson, Novartis, Mallinckrodt and Teva were each asked about one drug.
